PDF
Abstract
Depression is an important post-stroke sequela with negative impact on mortality, functional outcome and quality of life. Changes in cytokines have been hypothesized to be associated with the etiology of post-stroke depression (PSD). The altere dhypothalamic-pituitary-adrenal (HPA) functioning is associated with the onset of depression. The activity of HPA could induce the fluctuations of cortisol levels. In this study, we prospectively checked interleukin 6 (IL-6) and cortisol levels in patients with early ischemic stroke. It was hypothesized that early serum IL-6 and cortisol fluctuations in stroke patients were the predictions of PSD. Totally, 100 participants were selected from stroke inpatients consecutively admitted to the Department of Neurology, Tongji Hospital from July 2014 to December 2015. Fifty health people served as the controls. The serum of all the patients was collected at 8:00 am and 4:00 pm respectively one week after stroke. The serum of controls was collected only at 8:00 am. The levels of IL-6 were analyzed by enzyme-linked immunosorbent assay kit, and those of cortisol were detected by chemiluminescence immunoassay. On the 3rd week after stroke, the patients were enrolled to the PSD group and non-PSD group based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and The Hamilton Depression Rating Scale (HAMD-21, score>7). The IL-6 level (13.24±2.89 ng/L) was elevated significantly in PSD groups as compared with that in non-PSD group and control group respectively (P<0.05 for both), but there was no significant difference in the IL-6 level between non-PSD group and control group. The patients in both PSD group and non-PSD group had significantly elevated morning cortisol levels in comparison with those in the control group (P<0.05; for PSD, non-PSD and control: 508.86±119.51, 420.83±70.04 and 340.40±76.30 nmol/L respectively). Moreover, afternoon cortisol levels in PSD group were significantly higher than those in non-PSD group, and the morning baseline cortisol levels in these two groups were similar (P>0.05). It was suggested that PSD generally runs a chronic course and is related to a variety of adverse health outcomes including increased disability, morbidity and mortality. This study will help the screening of potential PSD in the early stage.
Keywords
post-stroke depression
/
interleukin 6
/
cortisol
Cite this article
Download citation ▾
Xiao-fan Zhang, Wei Zou, Yuan Yang.
Effects of IL-6 and cortisol fluctuations in post-stroke depression.
Current Medical Science, 2016, 36(5): 732-735 DOI:10.1007/s11596-016-1653-0
| [1] |
LuW, BianQ, SongYY, et al. . Prevalence and related risk factors of anxiety and depression among Chinese college freshmen. J Huazhong Univ Sci Technol (Med Sci), 2015, 35(06): 815-822
|
| [2] |
HachinskiV. Post-stroke depression, not to be underestimated. Lancet, 1999, 353(9166): 1728 PMID: 10347982
|
| [3] |
CarsonAJ, MacHaleS, AllenK, et al. . Depression after stroke and lesion location: a systematic review. Lancet, 2000, 356(9224): 122-126 PMID: 10963248
|
| [4] |
SchiepersOJ, WichersMC, MaesM. Cytokines and major depression. NEURO-PSYCHOPH, 2005, 29(2): 201-217
|
| [5] |
SpallettaG, BossuP, CiaramellaA, et al. . The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry, 2006, 11(11): 984-991 PMID: 16894392
|
| [6] |
CarrollBJ, FeinbergM, GredenJF, et al. . A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. JAMA Psychiatry, 1981, 38(1): 15-22
|
| [7] |
HolsboerF, Von BardelebenU, GerkenA, et al. . Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med, 1984, 311(17): 1127 PMID: 6090905
|
| [8] |
KatonWJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosc, 2011, 13(1): 7-23
|
| [9] |
MorrisPL, RobinsonRG, AndrzejewskiP, et al. . Association of depression with 10-year poststroke mortality. Am J Psychiatry, 1993, 150: 124 PMID: 8417554
|
| [10] |
LoubinouxI, KronenbergG, EndresM, et al. . Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med, 2012, 16(9): 1961-1969 PMID: 22348642 PMCID: 3822966
|
| [11] |
LiW, LingS, YangY, et al. . Systematic hypothesis for post-stroke depression caused inflammation and neurotransmission and resultant on possible treatments. Neuro Endocrinol Lett, 2014, 35(2): 104-109 PMID: 24878979
|
| [12] |
DaferRM, RaoM, ShareefA, et al. . Poststroke depression. Top Stroke Rehabil, 2008, 15(1): 13-21 PMID: 18250069
|
| [13] |
BelanoffJK, KalehzanM, SundB, et al. . Cortisol activity and cognitive changes in psychotic major depression. Am J Psychiatry, 2001, 158(10): 1612-1616 PMID: 11578992
|
| [14] |
RaisonCL, CapuronL, MillerAH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol, 2006, 27(1): 24-31 PMID: 16316783
|
| [15] |
DemirS, AtliA, BulutM, et al. . Neutrophil-lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy. Neuropsychiatr Dis Treat, 2015, 11: 2253 PMID: 26347335 PMCID: 4556257
|
| [16] |
MarquesAH, CizzaG, SternbergE. Brain-immune interactions and implications in psychiatric disorders. Rev Bras Psiquiatr, 2007, 29: s27-s32 PMID: 17546344
|
| [17] |
CapuronL, GumnickJF, MusselmanDL, et al. . Neurobehavioral effects of interferon-a in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology, 2002, 26(5): 643-652 PMID: 11927189
|
| [18] |
KnuthB, RadtkeV, RochaP, et al. . Prevalence of depression symptoms and serum levels of interleukin-6 in hemodialysis patients. Psychiatry Clin Neurosci, 2014, 68(4): 275-282 PMID: 24372974
|
| [19] |
DantzerR, O’ConnorJC, FreundGG, et al. . From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci, 2008, 9(1): 46-56 PMID: 18073775 PMCID: 2919277
|
| [20] |
KhairovaRA, Machado-VieiraR, DuJ, et al. . A potential role for proinflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol, 2009, 12(4): 561-578 PMID: 19224657 PMCID: 2771334
|
| [21] |
MeyerJH, GinovartN, BoovariwalaA, et al. . Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. JAMA Psychiatry, 2006, 63(11): 1209-1216
|
| [22] |
ResslerKJ, NemeroffCB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety, 2000, 12: 2-19 PMID: 11098410
|
| [23] |
WangQ, TangXN, YenariMA. The inflammatory response in stroke. J Neuroimmunol, 2007, 184(1): 53-68 PMID: 17188755
|
| [24] |
MehtaSL, ManhasN, RaghubirR. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev, 2007, 54(1): 34-66 PMID: 17222914
|
| [25] |
WebsterJI, TonelliL, SternbergEM. Neuroendocrine regulation of immunity. Annu Rev Immunol, 2002, 20(1): 125-163 PMID: 11861600
|
| [26] |
MillerAH, MaleticV, RaisonCL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry, 2009, 65(9): 732-741 PMID: 19150053 PMCID: 2680424
|
| [27] |
Nolen-HoeksemaS. Gender differences in depression. CDPS, 2001, 10(5): 173-176
|
| [28] |
GunnarMR, VazquezDM. Low cortisol and a flattening of expected daytime rhythm: Potential indices of risk in human development. Dev Psychopathol, 2001, 13(03): 515-538 PMID: 11523846
|
| [29] |
RobinsonRG, SpallettaG. Post-stroke depression: a review. Can J Psychiatry, 2010, 55(6): 341-349 PMID: 20540828 PMCID: 3647458
|
| [30] |
FlierJS, UnderhillLH, ChrousosGP. The hypothalamicpituitary-adrenal axis and immune-mediated inflammation. N Engl J Med, 1995, 332(20): 1351-1363
|
| [31] |
SaleMV, RiddingMC, NordstromMA. Cortisol inhibits neuroplasticity induction in human motor cortex. J Neurosci, 2008, 28(33): 8285-8293 PMID: 18701691
|
| [32] |
HunsbergerJG, AustinDR, ChenG, et al. . Cellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor-and mitochondrially-mediated plasticity. Brain Res, 2009, 1293: 76-84 PMID: 19595676 PMCID: 2804877
|
| [33] |
MeiselC, SchwabJM, PrassK, et al. . Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci, 2005, 6(10): 775-786 PMID: 16163382
|
| [34] |
JusterR-P, BizikG, PicardM, et al. . A transdisciplinary perspective of chronic stress in relation to psychopathology throughout life span development. Dev Psychopathol, 2011, 23(03): 725-776 PMID: 21756430
|
| [35] |
HoffmannSC, StanleyEM, CoxED, et al. . Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant, 2002, 2(6): 560-567 PMID: 12118901
|
| [36] |
LutgendorfSK, WeinribAZ, PenedoF, et al. . Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J Clin Oncol, 2008, 26(29): 4820-4827 PMID: 18779606 PMCID: 2653140
|